Primary Care–Initiated Continuous Glucose Monitoring in Adults With Insulin-Treated Diabetes
-
By
-
Jovan Milosavljevic
-
Lorena Rasquin Leon
-
Sharon Rikin
-
Clyde Schechter
-
Sybil Hodgson
-
Shivani Agarwal
-
July 6, 2026
-
Clinical Scorecard: Initiating Continuous Glucose Monitoring in Insulin-Treated Adults Through Primary Care
At a Glance
| Category | Detail |
|---|
| Condition | Diabetes |
| Key Mechanisms | Continuous glucose monitoring (CGM) reduces hemoglobin A1c (HbA1c) levels and improves clinical outcomes. |
| Target Population | Adults with any type of diabetes treated with insulin. |
| Care Setting | Primary care settings. |
Key Highlights
- CGM is recommended by the American Diabetes Association for insulin-treated diabetes.
- CGM use can improve HbA1c levels and reduce hospitalizations and ED visits.
- Adoption of CGM in primary care remains limited despite its proven benefits.
Guideline-Based Recommendations
Diagnosis
- Patients with diabetes should be assessed for CGM eligibility based on insulin treatment.
Management
- Primary care clinicians should initiate CGM for eligible patients to improve diabetes management.
Monitoring & Follow-up
- Regular monitoring of HbA1c levels and clinical outcomes is essential after CGM initiation.
Risks
- Potential barriers to CGM adoption include clinician perspectives and patient access.
Patient & Prescribing Data
Predominantly Hispanic and Black patients in a large primary care network.
CGM is covered under Medicaid for insulin-treated diabetes patients in New York State.
Clinical Best Practices
- Integrate CGM into primary care for better diabetes management.
- Utilize EHR data to identify eligible patients for CGM.
Related Resources & Content
